tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BOLT Stock Latest News

Buy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
RatingsBuy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
17d ago
BOLT
Bolt Biotherapeutics Reports Improved Financial Performance
PremiumCompany Announcements
Bolt Biotherapeutics Reports Improved Financial Performance
18d ago
BOLT
Bolt Biotherapeutics reports Q3 EPS ($3.72), consensus ($5.39)
PremiumThe Fly
Bolt Biotherapeutics reports Q3 EPS ($3.72), consensus ($5.39)
18d ago
BOLT
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
PremiumCompany Announcements
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
1M ago
BOLT
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
PremiumRatings
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
1M ago
BOLT
Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright
PremiumThe FlyBolt Biotherapeutics assumed with a Buy at H.C. Wainwright
1M ago
BOLT
Bolt Biotherapeutics Announces Major Restructuring Plan
Premium
Company Announcements
Bolt Biotherapeutics Announces Major Restructuring Plan
2M ago
8K
BOLT
Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study
Premium
The Fly
Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study
2M ago
BOLT
Bolt Biotherapeutics Reports Reduced Losses and Revenue Growth
PremiumCompany Announcements
Bolt Biotherapeutics Reports Reduced Losses and Revenue Growth
3M ago
BOLT
Cautious Hold Rating on Bolt Biotherapeutics Amid Uncertain Trial Outcomes and Financial Sustainability
PremiumRatings
Cautious Hold Rating on Bolt Biotherapeutics Amid Uncertain Trial Outcomes and Financial Sustainability
4M ago
BOLT
Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
PremiumThe Fly
Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
4M ago
BOLT
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
PremiumThe Fly
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
4M ago
BOLT
Bolt Biotherapeutics Inc trading halted, news pending
PremiumThe FlyBolt Biotherapeutics Inc trading halted, news pending
6M ago
BOLT
Bolt Biotherapeutics Announces Reverse Stock Split
Premium
Company Announcements
Bolt Biotherapeutics Announces Reverse Stock Split
6M ago
8K
BOLT
Bolt Biotherapeutics Announces Reverse Stock Split Approval
Premium
Company Announcements
Bolt Biotherapeutics Announces Reverse Stock Split Approval
6M ago
8K
BOLT
Bolt Biotherapeutics Approves Key Governance Changes
PremiumCompany Announcements
Bolt Biotherapeutics Approves Key Governance Changes
6M ago
8K
BOLT
Bolt Biotherapeutics initiated with a Buy at Lake Street
PremiumThe Fly
Bolt Biotherapeutics initiated with a Buy at Lake Street
6M ago
BOLT
GMAB
Cautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
PremiumRatings
Cautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
7M ago
BOLT
Cautious Hold Rating on Bolt Biotherapeutics Amid Promising Clinical Data and Financial Uncertainty
PremiumRatings
Cautious Hold Rating on Bolt Biotherapeutics Amid Promising Clinical Data and Financial Uncertainty
7M ago
BOLT
Bolt Biotherapeutics price target lowered to $1 from $1.25 at Stifel
PremiumThe FlyBolt Biotherapeutics price target lowered to $1 from $1.25 at Stifel
7M ago
BOLT
Bolt Biotherapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Bolt Biotherapeutics Reports Q1 2025 Financial Results
7M ago
BOLT
Bolt Biotherapeutics reports Q1 EPS (29c), consensus (36c)
Premium
The Fly
Bolt Biotherapeutics reports Q1 EPS (29c), consensus (36c)
7M ago
BOLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >